Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORTHOPEDIATRICS CORP Director's Dealing 2017

Oct 11, 2017

32906_dirs_2017-10-11_9e85ca0a-5b6b-4461-a6a9-47ecbb3dc828.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ORTHOPEDIATRICS CORP (KIDS)
CIK: 0001425450
Period of Report: 2017-10-11

Reporting Person: Squadron Capital LLC (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1206 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $30.97 2022-08-23 Common Stock (1340) Direct
Series A Convertible Preferred Stock $23.88 Common Stock (670000) Direct
Series B Convertible Preferred Stock $13.09 Common Stock (2785833) Direct

Footnotes

F1: The stock option is fully vested and immediately exercisable.

F2: All outstanding shares of Series A Convertible Preferred Stock (the "Series A Stock") are held by the reporting person. The Series A Stock is convertible at any time at the reporting person's election into shares of Common Stock at the then-existing conversion price, and has no expiration date. Upon the closing of the initial public offering of the Common Stock, a $16.0 million preference payment, together with all accrued and unpaid dividends, on the Series A Stock will automatically convert into shares of Common Stock at a conversion price equal to the initial public offering price.

F3: The Series B Convertible Preferred Stock is convertible at any time at the holder's election into shares of Common Stock at the then-existing conversion price, and has no expiration date.